Evidence map›Paper›PMID 33669095›Full record

ArticlePharmaceuticals (Basel, Switzerland)2021

Development and Validation of a GMP-Compliant High-Pressure Liquid Chromatography Method for the Determination of the Chemical and Radiochemical Purity of [

Ines Katzschmann, Heike Marx, Klaus Kopka, Ute Hennrich

Open access · goldAbstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. A comparative assessment of radiochemical purity and yield of [EJNMMI radiopharmacy and chemistry · 2026
    Article
  2. Quality control of [EJNMMI radiopharmacy and chemistry · 2022
    Article
  3. Article
  4. On site production of [EJNMMI radiopharmacy and chemistry · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ines KatzschmannGerman Cancer Research Center (DKFZ), Division of Radiology, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
Heike MarxGerman Cancer Research Center (DKFZ), Division of Radiology, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
Klaus KopkaGerman Cancer Consortium (DKTK), 69120 Heidelberg, Germany.
Ute HennrichGerman Cancer Research Center (DKFZ), Division of Radiology, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.ORCID 0000-0003-4198-1899
German Cancer Research Center · DE

Funding

Bundesministerium für Bildung und Forschung 01DR17031A
6 · The paper itself

Abstract

For the PET imaging of prostate cancer, radiotracers targeting the prostate-specific membrane antigen (PSMA) are nowadays used in clinical practice. [

Indexed as

[18F]PSMA-1007GMPhigh performance liquid chromatography (HPLC)positron emission tomography (PET)prostate cancerPSMAvalidation

Identifiers

PMID33669095
PMCPMC7996543
OpenAlexW3129564815

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.